BANK OF AMERICA CORP /DE/ - AVADEL PHARMACEUTICALS PLC ownership

AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 87 filers reported holding AVADEL PHARMACEUTICALS PLC in Q2 2022. The put-call ratio across all filers is 0.83 and the average weighting 0.1%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of AVADEL PHARMACEUTICALS PLC
ValueSharesWeighting
Q3 2023$2,285,230
+224.9%
221,867
+419.8%
0.00%
Q2 2023$703,384
-88.9%
42,681
-93.8%
0.00%
-100.0%
Q1 2023$6,340,790
+735.6%
692,226
+553.2%
0.00%
Q4 2022$758,809
+116.2%
105,979
+51.1%
0.00%
Q3 2022$351,000
+93.9%
70,126
-5.7%
0.00%
Q2 2022$181,000
-88.8%
74,380
-68.7%
0.00%
Q1 2022$1,621,000
+199.1%
237,331
+253.2%
0.00%
Q4 2021$542,000
+98.5%
67,195
+141.7%
0.00%
Q3 2021$273,000
-27.4%
27,798
-50.2%
0.00%
Q2 2021$376,000
+0.5%
55,838
+34.8%
0.00%
Q1 2021$374,000
+179.1%
41,413
+105.8%
0.00%
Q4 2020$134,000
+36.7%
20,127
+3.2%
0.00%
Q3 2020$98,000
-26.3%
19,500
+18.1%
0.00%
Q2 2020$133,000
+454.2%
16,505
+450.2%
0.00%
Q1 2020$24,000
+100.0%
3,000
-37.7%
0.00%
Q4 2018$12,000
-73.9%
4,819
-54.6%
0.00%
Q3 2018$46,000
+64.3%
10,604
+130.8%
0.00%
Q2 2018$28,000
+12.0%
4,595
+29.3%
0.00%
Q1 2018$25,000
-87.9%
3,554
-85.9%
0.00%
Q4 2017$207,000
-55.6%
25,222
-43.3%
0.00%
Q3 2017$466,000
+19.5%
44,449
+25.9%
0.00%
Q2 2017$390,000
+23.0%
35,304
+7.8%
0.00%
Q1 2017$317,00032,7530.00%
Other shareholders
AVADEL PHARMACEUTICALS PLC shareholders Q2 2022
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 985,210$10,345,0006.10%
Broadfin Capital, LLC 3,568,122$37,465,0005.54%
JW Asset Management, LLC 444,439$4,667,0003.42%
ARMISTICE CAPITAL, LLC 1,688,000$17,724,0002.09%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,655,494$38,383,0001.73%
FALCON POINT CAPITAL, LLC 661,490$6,284,0000.91%
KNOTT DAVID M 158,555$1,665,0000.71%
Perceptive Advisors 3,098,010$32,530,0000.62%
Sio Capital Management, LLC 91,413$960,0000.50%
HEARTLAND ADVISORS INC 700,000$7,350,0000.48%
View complete list of AVADEL PHARMACEUTICALS PLC shareholders